Doxorubicin Supplier-Buyer Network — Trade Flow Analysis

Name: Doxorubicin Supplier-Buyer Trade Network Dataset — 310+ Indian Exporters, 19+ Importers, 136+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Doxorubicin supplier network, Doxorubicin buyers, pharmaceutical export India, Doxorubicin trade data

TransData Nexus

Doxorubicin

India Pharmaceutical Trade Intelligence

$67.3M310 Suppliers136 CountriesHS 30049046

ExportsIndia → UNITED STATES39.4%India → CANADA18.9%

ImportsAUSTRALIA → India$16.6M BELGIUM → India$508.7K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: TARO PHARMACEUTICALS

Who Supplies Doxorubicin? Top Manufacturers & Buyers 2026 — SUN PHARMACEUTICAL INDUSTRIES LIMITED Leads | TransData Nexus | TransData Nexus

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Doxorubicin exporter from India, with a market share of 23.7% and a total export value of $15.9M across 149 shipments. Their average shipment value of $106.8K is above the market average of $19.3K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TARO PHARMACEUTICALS INC — $6.9M across 65 shipments (43.3% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES, INC. — $3.2M across 30 shipments (20.2% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES, INC. — $2.6M across 24 shipments (16.2% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES, INC. — $2.0M across 19 shipments (12.5% of this supplier's total exports)

• RXCROSSROADS 3PL LLC — $1.2M across 12 shipments (7.8% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $106.8K is 455% above the market average of $19.3K, consistent with large-order contracts or value-added formulations.

2DR.REDDY'S LABORATORIES LTD

DR.REDDY'S LABORATORIES LTD is the second-largest Doxorubicin exporter from India, with a market share of 4.0% and a total export value of $2.7M across 51 shipments. Their average shipment value of $52.4K is above the market average of $19.3K, suggesting premium or bulk contract pricing.

DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DR REDDYS LABORATORIES INC — $1.0M across 19 shipments (38.1% of this supplier's total exports)

• SUDAIR PHARMA UNIT 6 — $575.7K across 11 shipments (21.6% of this supplier's total exports)

• NORTHSTAR RX LLC — $482.2K across 9 shipments (18.1% of this supplier's total exports)

• INCEPTUA INC C/O J. — $298.9K across 6 shipments (11.2% of this supplier's total exports)

• SAB P.O — $296.9K across 6 shipments (11.1% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LTD's per-shipment value of $52.4K is 172% above the market average of $19.3K, consistent with large-order contracts or value-added formulations.

3DR.REDDY'S LABORATORIES LIMITED

DR.REDDY'S LABORATORIES LIMITED is the third-largest Doxorubicin exporter from India, with a market share of 3.3% and a total export value of $2.2M across 10 shipments. Their average shipment value of $218.6K is above the market average of $19.3K, suggesting premium or bulk contract pricing.

DR.REDDY'S LABORATORIES LIMITED serves 4 named buyers in our database. DR REDDYS LABORATORIES INC is the dominant customer, accounting for 60.2% of this supplier's tracked business. Top customers include:

• DR REDDYS LABORATORIES INC — $1.3M across 6 shipments (60.2% of this supplier's total exports)

• SAB P.O BOX67 JEDDAH — $642.0K across 3 shipments (29.4% of this supplier's total exports)

• AMERISOURCE HEALTH S — $194.4K across 1 shipments (8.9% of this supplier's total exports)

• DR. REDDYS LABORATOR — $33.2K across 0 shipments (1.5% of this supplier's total exports)

Key Insight: DR.REDDY'S LABORATORIES LIMITED's per-shipment value of $218.6K is 1035% above the market average of $19.3K, consistent with large-order contracts or value-added formulations.

4DR REDDYS LABORATORIES LIMITED

DR REDDYS LABORATORIES LIMITED is the fourth-largest Doxorubicin exporter from India, with a market share of 3.1% and a total export value of $2.1M across 11 shipments. Their average shipment value of $192.3K is above the market average of $19.3K, suggesting premium or bulk contract pricing.

DR REDDYS LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DR REDDYS LABORATORIES INC — $1.0M across 5 shipments (47.5% of this supplier's total exports)

• NORTHSTAR RX LLC — $716.7K across 4 shipments (33.9% of this supplier's total exports)

• AMERISOURCE HEALTH S — $283.3K across 1 shipments (13.4% of this supplier's total exports)

• INCEPTUA INC C O J K — $85.6K across 0 shipments (4.0% of this supplier's total exports)

• DR REDDYS LABORATORIES INC — $25.4K across 0 shipments (1.2% of this supplier's total exports)

Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $192.3K is 898% above the market average of $19.3K, consistent with large-order contracts or value-added formulations.

5FRESENIUS KABI ONCOLOGY LIMITED

FRESENIUS KABI ONCOLOGY LIMITED is the fifth-largest Doxorubicin exporter from India, with a market share of 1.9% and a total export value of $1.3M across 143 shipments. Their average shipment value of $8.9K is below the market average of $19.3K, reflecting a high-volume, competitive pricing strategy.

FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FRESENIUS KABI (THAI — $357.9K across 40 shipments (28.2% of this supplier's total exports)

• FRESENIUS KABI (THAI — $269.4K across 30 shipments (21.2% of this supplier's total exports)

• FRESENIUS KABI (THAI — $254.2K across 29 shipments (20.0% of this supplier's total exports)

• ATCO PHARMA INTERNAT — $208.8K across 23 shipments (16.4% of this supplier's total exports)

• FRESENIUS KABI COLOM — $180.9K across 20 shipments (14.2% of this supplier's total exports)

Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (143 shipments) at a per-shipment value of $8.9K, indicating a broad distribution network with many smaller, regular orders.

6INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the fifth-largest Doxorubicin exporter from India, with a market share of 1.4% and a total export value of $917.1K across 393 shipments. Their average shipment value of $2.3K is below the market average of $19.3K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER — $449.3K across 193 shipments (49.0% of this supplier's total exports)

• ACCORD FARMACEUTICA — $182.7K across 78 shipments (19.9% of this supplier's total exports)

• ACCORD HEALTHCARE PO — $138.4K across 59 shipments (15.1% of this supplier's total exports)

• brocacef NL HUB — $79.9K across 34 shipments (8.7% of this supplier's total exports)

• XXCORXXHEAXXHCAXX PT — $67.0K across 29 shipments (7.3% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (393 shipments) at a per-shipment value of $2.3K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Doxorubicin imports from India, with a total trade value of $26.5M across 102 shipments — representing a 39.4% share of all Doxorubicin exports. The average shipment value of $259.9K is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.

Named Doxorubicin importers in United States: DR REDDYS LABORATORIES,INC is the largest buyer, accounting for 26.3% ($7.0M) of this market's total imports.

• DR REDDYS LABORATORIES,INC — $7.0M (26.3% of United States's total)

• SUN PHARMACEUTICAL INDUSTRIES,INC. — $3.7M (14.0% of United States's total)

• SUN PHARMACEUTICAL INDUSTRIES INC — $2.7M (10.2% of United States's total)

Key Insight: United States's per-shipment average of $259.9K (1250% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Doxorubicin imports from India.

Primary Market

Secondary Market

2Canada

Canada ranks as the second-largest destination for Doxorubicin imports from India, with a total trade value of $12.7M across 15 shipments — representing a 18.9% share of all Doxorubicin exports. The average shipment value of $848.7K is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Doxorubicin importers in Canada: TARO PHARMACEUTICALS INC. is the largest buyer, accounting for 60.7% ($7.7M) of this market's total imports.

• TARO PHARMACEUTICALS INC. — $7.7M (60.7% of Canada's total)

• TARO PHARMACEUTICALS INC — $2.4M (19.0% of Canada's total)

• TARO PHARMACEUTICAL INC. — $2.4M (18.6% of Canada's total)

Key Insight: Canada's per-shipment average of $848.7K (4306% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Doxorubicin imports from India.

Primary Market

Secondary Market

3Mozambique

Mozambique ranks as the third-largest destination for Doxorubicin imports from India, with a total trade value of $3.1M across 7 shipments — representing a 4.7% share of all Doxorubicin exports. The average shipment value of $448.2K is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Doxorubicin importers in Mozambique: MINISTERIO DA SAUDE/ is the largest buyer, accounting for 28.7% ($899.5K) of this market's total imports.

• MINISTERIO DA SAUDE/ — $899.5K (28.7% of Mozambique's total)

• MINISTRIO DA SADE/ — $808.0K (25.8% of Mozambique's total)

Key Insight: Mozambique's per-shipment average of $448.2K (2227% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Mozambique is a key market for Doxorubicin imports from India.

Primary Market

Secondary Market

4Vietnam

Vietnam ranks as the fourth-largest destination for Doxorubicin imports from India, with a total trade value of $2.9M across 9 shipments — representing a 4.4% share of all Doxorubicin exports. The average shipment value of $327.5K is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Doxorubicin importers in Vietnam: HAPHARCO J S C BRANCH is the largest buyer, accounting for 33.9% ($998.5K) of this market's total imports.

• HAPHARCO J S C BRANCH — $998.5K (33.9% of Vietnam's total)

• HAPHARCOJ S CBRANCH — $995.8K (33.8% of Vietnam's total)

• HAPHARCO J.S.C BRANCH — $952.0K (32.3% of Vietnam's total)

Key Insight: Vietnam's per-shipment average of $327.5K (1601% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Vietnam is a key market for Doxorubicin imports from India.

Primary Market

Secondary Market

5Saudi Arabia

Saudi Arabia ranks as the fifth-largest destination for Doxorubicin imports from India, with a total trade value of $2.2M across 0 shipments — representing a 3.2% share of all Doxorubicin exports. The average shipment value of $2.2M is above the global average of $19.3K, indicating high-value procurement contracts or branded formulations.

Key Insight: Saudi Arabia's per-shipment average of $2.2M (11176% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Saudi Arabia is a key market for Doxorubicin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Doxorubicin.
2.Flow Mapping: 310 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,492 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 136 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,492 Verified Shipments

310 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Doxorubicin

Doxorubicin

Who Supplies Doxorubicin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Doxorubicin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Doxorubicin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

2DR.REDDY'S LABORATORIES LTD

3DR.REDDY'S LABORATORIES LIMITED

4DR REDDYS LABORATORIES LIMITED

5FRESENIUS KABI ONCOLOGY LIMITED

6INTAS PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Doxorubicin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Doxorubicin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Canada

3Mozambique

4Vietnam

5Saudi Arabia

People Also Ask — Doxorubicin Supplier & Trade Network

Doxorubicin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology